@tegan_jonas's peptide protocol hype, fact-checked

What did @tegan_jonas actually say?

Honestly? Very little that's verifiable. The transcript appears to be garbled or possibly song lyrics. The actual words recorded, "Every second every minute is true / Alone for the one with the young braise / Wish I'd not see your face," don't constitute any medical or peptide-related claim. The real content is the caption, which promotes something called "BioStacking" and a "Peptide Protocol" under the brand "The Rise Method." That's what we're actually fact-checking here.

The caption leans entirely on aspirational language: "That feeling isn't jealousy. It's your future self waking up." There are no specific peptide claims in the spoken transcript because there is no coherent spoken transcript. What exists instead is a branded hashtag campaign, #PeptideProtocol and #BioStacking, attached to a 25,000-plus-view post, doing the marketing work that explicit claims might get flagged for.

Does the science back this up?

There's legitimate research on some peptides in this category, but it's narrower and more preliminary than "Peptide Protocol" branding implies. BPC-157 has shown regenerative effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but no completed human RCTs exist. CJC-1295 paired with ipamorelin does stimulate growth hormone release, confirmed in small human trials (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism), but the leap from "stimulates GH" to "optimizes your body" is a big one.

MK-677, often marketed alongside these peptides, is an investigational compound. It's not a peptide. It's a growth hormone secretagogue with a mixed safety profile, including reported insulin resistance and increased appetite (Nass et al., 2008, Annals of Internal Medicine). GHK-Cu shows interesting wound-healing signals in vitro (Pickart et al., 2015, Journal of Aging Research), but in vitro is not your skin. Semax and Selank have some Russian clinical literature behind them, mostly in neurological contexts, but these are not FDA-reviewed data sets.

What did they get wrong (or right)?

What they got wrong: Framing a multi-compound "protocol" as a lifestyle upgrade without any disclosure of risks, regulatory status, or the simple fact that most of these compounds are not FDA-approved for general wellness use. "BioStacking" sounds scientific. It is not a recognized clinical term. Stacking multiple peptides and secretagogues simultaneously introduces interaction variables that have not been studied in combination. No one can honestly tell you what CJC-1295 plus BPC-157 plus MK-677 does together in a human body over six months, because that study doesn't exist.

What they possibly got right: Some of the individual peptides in the category do have real mechanistic science behind them. TB-500 (thymosin beta-4) has genuine anti-inflammatory signaling data. This isn't snake oil from start to finish. But promising mechanisms in a lab, or in a mouse tendon, are not the same as a validated human protocol. The marketing skips that gap entirely.

What should you actually know?

Most peptides marketed for optimization are sold as "research chemicals" specifically because they have not cleared the FDA approval process for human use. That designation is a legal workaround, not a safety certification. Compounded versions of these peptides, which is how most telehealth platforms dispense them, are not equivalent to any FDA-approved drug. The FDA issued warning letters in 2023 targeting compounded BPC-157 specifically, citing lack of evidence for its use as a compounded drug.

If you're considering peptide therapy through any platform, including regulated telehealth services, ask your provider three things: What is the evidence base for this specific compound in humans? What are the known side effects and contraindications? Is this compound currently on the FDA's list of withdrawn bulk drug substances? Those questions will tell you more than any Instagram caption. "Become her" is not a clinical indication.